Related content

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population

By Scott Stuart A   Edelmann Lisa   Kornreich Ruth   Erazo Monica   Desnick Robert J  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 721-730

Future Medicine

Access to resources Recommend Favorite

Allele Frequency Distributions of the Drug Metabolizer Genes CYP2C9*2, CYP2C9*3, and CYP2C19*17 in the Buginese Population of Indonesia

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 4, 2014-12 ,pp. : 236-239

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients

By Dandara Collet   Mutowembwa Masimirembwa Collen   Magimba Ayoub   Sayi Jane   Kaaya Sylvia   Sommers De K.   Snyman J.R.   Hasler Julia Anne  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 1, 2001-04 ,pp. : 11-17

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of the genetic profile of CYP2C19 in two South African populations

By Drögemöller Britt I   Wright Galen EB   Niehaus Dana JH   Koen Liezl   Malan Stefanie   Da Silva Danielle M   Hillermann–Rebello Renate   La Grange Anthony M   Venter Mauritz   Warnich Louise  

Pharmacogenomics, Vol. 11, Iss. 8, 2010-08 ,pp. : 1095-1103

Future Medicine

Access to resources Recommend Favorite

The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance

By  

Current Clinical Pharmacology, Vol. 2, Iss. 1, 2007-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite